类风湿关节炎相关间质性肺病的危险因素分析
Analysis of Risk Factors for Rheumatoid Arthritis-Associated Interstitial Lung Disease
DOI: 10.12677/acm.2025.15103038, PDF,   
作者: 李玉婷:赣南医科大学第一临床医学院,江西 赣州;曾治平*:赣南医科大学第一附属医院全科医学科,江西 赣州
关键词: 类风湿关节炎间质性肺病危险因素Rheumatoid Arthritis Interstitial Lung Disease Risk Factors
摘要: 类风湿关节炎(rheumatoid arthritis, RA)是一种以慢性滑膜炎、血管翳形成和骨关节破坏为主要病理特征的系统性自身免疫病。类风湿关节炎相关间质性肺病(rheumatoid arthritis-associated Interstitial lung disease, RA-ILD)是其肺部受累最常见的表现形式。ILD早期以间质性炎症为主,晚期则进展为肺纤维化,最终可导致呼吸功能衰竭甚至死亡,显著影响患者的发病与死亡风险。由于RA-ILD起病隐匿,早期识别其危险因素对预防该并发症具有重要意义。本文就近年来RA-ILD相关危险因素的研究进展作一综述。
Abstract: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized pathologically by chronic synovitis, pannus formation, and destruction of bones and joints. Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) represents the most common form of pulmonary involvement in RA. In its early stages, ILD is primarily characterized by interstitial inflammation, which progresses to pulmonary fibrosis in advanced phases, ultimately leading to respiratory failure and even death, significantly impacting patient morbidity and mortality risks. Due to its insidious onset, early identification of risk factors is of great importance for preventing this complication. This article reviews recent advances in the study of risk factors associated with RA-ILD.
文章引用:李玉婷, 曾治平. 类风湿关节炎相关间质性肺病的危险因素分析[J]. 临床医学进展, 2025, 15(10): 2511-2517. https://doi.org/10.12677/acm.2025.15103038

参考文献

[1] 任婷婷, 李鸿斌. 超声在结缔组织病相关肺间质病变中的应用[J]. 中国实用内科杂志, 2020, 40(2): 166-169, 173.
[2] 丰建文, 吴玉枝. 基于Lasso-Logistic回归分析的类风湿性关节炎相关间质性肺病风险预测模型构建[J]. 临床肺科杂志, 2024, 29(11): 1638-1643.
[3] 杨焕丽, 郭团茂, 刘茹. 类风湿关节炎相关间质性肺病风险因素的Meta分析[J]. 临床医学研究与实践, 2024, 9(26): 29-33, 122.
[4] 王梦伟. 类风湿关节炎相关间质性肺病的临床特征和危险因素研究[D]: [硕士学位论文]. 芜湖: 皖南医学院, 2024.
[5] 陈旭, 石蓉蓉, 郭东更. 类风湿关节炎相关间质性肺病的临床特征及危险因素分析[J]. 内蒙古医学杂志, 2023, 55(12): 1417-1421.
[6] 李梦雪. 类风湿关节炎相关间质性肺病临床特点及相关危险因素研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2022.
[7] Natalini, J.G., Baker, J.F., Singh, N., Mahajan, T.D., Roul, P., Thiele, G.M., et al. (2021) Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans. Annals of the American Thoracic Society, 18, 598-605. [Google Scholar] [CrossRef] [PubMed]
[8] Mena-Vázquez, N., Godoy-Navarrete, F.J., Lisbona-Montañez, J.M., Redondo-Rodriguez, R., Manrique-Arija, S., Rioja, J., et al. (2023) Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease. International Journal of Molecular Sciences, 24, Article 6800. [Google Scholar] [CrossRef] [PubMed]
[9] Zheng, M., Lou, A., Zhang, H., Zhu, S., Yang, M. and Lai, W. (2021) Serum KL-6, CA19-9, CA125 and CEA Are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population. Rheumatology and Therapy, 8, 517-527. [Google Scholar] [CrossRef] [PubMed]
[10] 马杰桃. 类风湿关节炎合并间质性肺病的血清学特点及KL-6的临床应用价值分析[D]: [硕士学位论文]. 广州: 暨南大学, 2022.
[11] 薛乐乐. 类风湿关节炎相关间质性肺病的影像学特征及相关危险因素研究[D]: [硕士学位论文]. 晋中: 山西医科大学, 2024.
[12] Chai, D., Sun, D., Wang, Y., Song, Y., Wu, N. and Ye, Q. (2023) Progression of Radiographic Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Frontiers in Medicine, 10, Article 1265355. [Google Scholar] [CrossRef] [PubMed]
[13] Venerito, V., Manfredi, A., Carletto, A., Gentileschi, S., Atzeni, F., Guiducci, S., et al. (2023) Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study. Journal of Clinical Medicine, 12, Article 957. [Google Scholar] [CrossRef] [PubMed]